Generation shift in Dong-A

Published: 2013-05-27 06:58:00

Updated: 2013-05-27 06:58:00

The nation’s major pharmaceutical company is undergoing a generation shift that will bring changes to the local pharmaceutical industry landscape.

Dong-A Socio Group Chairman Kang Shin-ho on Thursday handed down his entire stake of Dong-A ST (357,935 shares) and Dong-A Socio Holdings (211,308 ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK